跳至主要内容
临床试验/JPRN-UMIN000005275
JPRN-UMIN000005275已完成未知

Effect of cefepime (CFPM) or meropenem (MEPM) for febrile neutropenia patients with lung cancer. Randomized phase II study. - Febrile neutropenia patients with lung cancer. CFPM vs MEPM

OGIK(Lung oncology group in Kyushu)0 个研究点目标入组 46 人开始时间: 2011年3月18日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
46

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Patient who is too severely ill 2. A history of cardiac failure, renal failure, or liver damage. 3. A known history of hypersensitivity to cephalosporins 4. A known history of allergy 5. Patient who demonstrated positive for skin reaction test ( if skin reaction test was done) 6. Patient who is not evaluated for response 7. Pregnant or lactating women. 8. Patient administered with sodium valproate 9. Patients administered with prohibiting medication (such as other antibiotics, gamma-globulin, corticosteroid, furosemide) 10.patient who is judged as an inappropriate case by the doctor in charge

研究者

发起方
OGIK(Lung oncology group in Kyushu)

相似试验